cimb-logo

Journal Browser

Journal Browser

Cell Junctions and Cell Adhesions in Physiology and Diseases

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 1360

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cell Physiology and Metabolism, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland
Interests: cancer therapy; drug development; biomarker; cell junctions; cell adhesion; permeability; leukocyte infiltration; cadherin; cell adhesions; integrins; chemokines; proteases; cell migration; inflammation; cancer

Special Issue Information

Dear Colleagues,

In order to sense and communicate with their microenvironment, adherent cells, including epithelial, endothelial and mesenchymal cells, rely on two main types of cell contact: cell–cell junctions between neighboring cells and cell adhesions between the cells and the extracellular matrix (ECM). The dysregulation of cell–cell junctions and cell–ECM adhesions contributes to tissue dysfunctions, the pathogenesis of several diseases and alters drug delivery in cancer therapy. Understanding the molecular mechanisms that control these two cell-contact structures and their intercommunication is vital for tissue regenerative medicine, as well as the development of efficient therapeutic drugs in cancers and inflammatory diseases.

Cell–cell contacts contribute to intercellular communication, the transport of fluid and solutes, and maintain barrier functions and tissue stability. Cell junctions are particularly perturbed by substances such as growth factors, cytokines, hormones and drugs in pathological conditions, which cause the uncontrolled infiltration of fluid and immune cells. How to efficiently keep homeostatic cell–cell junctions under control is a question that remains unresolved.

On the other hand, cell–ECM adhesions, mainly mediated by integrin receptors, are crucial for the synthesis of matrix components (i.e., fibrosis), cell migration, cell physiology and more recently, for the regulation of intercellular junctions. Recent studies have indicated that cell adhesions, their transmembrane receptors such as integrins, and adapter proteins such as Talins, Kindlins and Tensins significantly contribute to the control of cell–cell junctions in both physiological and pathological conditions. It is now conceivable that molecular tools could be efficiently employed to target cell–ECM adhesions and consequently control cell junctions, as well as the excessive infiltration of tissue fluid and immune cells.

Several questions regarding the molecular mechanisms, technical challenges, therapeutic developments and unresolved mechanistic controversies related to cell junctions and cell adhesions, as well as their intercommunication in physiology and pathophysiology, need to be addressed.

The aim of this Special Issue in CIMB is to collect original articles, as well as reviews, discussing these questions. The scope of this issue includes, but is not limited to, mechanistic insights into in vivo and in vitro works related to the following topics:

  • Cell–cell junctions in physiology and pathophysiology
  • Cell adhesions in physiology and pathophysiology
  • Intercommunication between components of cell–ECM adhesions and cell–cell junctions
  • Control of vascular permeability and fluid infiltration into peripheral tissues
  • Cell junction-mediated control of leukocyte diapedesis
  • Role of cell adhesion and migration in cancer
  • Cell junctions and adhesion receptors in matrix synthesis and fibrosis
  • Post-translational modifications to the components of cell adhesions and junctions
  • Drug development: targeting cell junctions and cell adhesion components in diseases

Dr. Adama Sidibé
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tight junctions
  • adherens junctions
  • cell adhesions
  • ECM
  • fibrosis
  • cadherin
  • integrins
  • adapters
  • permeability
  • migration
  • cancer
  • drug development

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 1825 KiB  
Article
Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer
by Ioannis A. Voutsadakis
Curr. Issues Mol. Biol. 2023, 45(11), 8670-8686; https://doi.org/10.3390/cimb45110545 - 28 Oct 2023
Viewed by 1003
Abstract
Metastatic colon cancer remains incurable despite improvements in survival outcomes. New therapies based on the discovery of colon cancer genomic subsets could improve outcomes. Colon cancers from genomic studies with publicly available data were examined to define the expression and regulation of the [...] Read more.
Metastatic colon cancer remains incurable despite improvements in survival outcomes. New therapies based on the discovery of colon cancer genomic subsets could improve outcomes. Colon cancers from genomic studies with publicly available data were examined to define the expression and regulation of the major tight junction proteins claudins and occludin in genomic groups. Putative regulations of the promoters of tight junction genes by colon-cancer-deregulated pathways were evaluated in silico. The effect of claudin mRNA expression levels on survival of colon cancer patients was examined. Common mutations in colon-cancer-related genes showed variable prevalence in genomically identified groups. Claudin genes were rarely mutated in colon cancer patients. Genomically identified groups of colon cancer displayed distinct regulation of claudins and occludin at the mRNA level. Claudin gene promoters possessed clustered sites of binding sequences for transcription factors TCF4 and SMADs, consistent with a key regulatory role of the WNT and TGFβ pathways in their expression. Although an effect of claudin mRNA expression on survival of colon cancer patients as a whole was not prominent, survival of genomic subsets was significantly influenced by claudin mRNA expression. mRNA expression of the main tight junction genes showed differential regulation in various genomically defined subgroups of colon cancer. These data pinpoint a distinct role of claudins and pathways that regulate them in these subgroups and suggest that subgroups of colon cancer should be considered in future efforts to therapeutically target claudins. Full article
(This article belongs to the Special Issue Cell Junctions and Cell Adhesions in Physiology and Diseases)
Show Figures

Figure 1

Back to TopTop